Lincoln National Corp’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,034
| Closed | -$466K | – | 1054 |
|
|
2023
Q1 | $466K | Sell |
13,034
-65
| -0.5% | -$2.32K | 0.01% | 614 |
|
|
2022
Q4 | $495K | Buy |
13,099
+269
| +2% | +$10.2K | 0.01% | 541 |
|
|
2022
Q3 | $567K | Sell |
12,830
-431
| -3% | -$19K | 0.01% | 460 |
|
|
2022
Q2 | $491K | Hold |
13,261
| – | – | 0.01% | 485 |
|
|
2022
Q1 | $491K | Sell |
13,261
-809
| -6% | -$30K | 0.01% | 530 |
|
|
2021
Q4 | $428K | Sell |
14,070
-200
| -1% | -$6.08K | 0.01% | 582 |
|
|
2021
Q3 | $479K | Sell |
14,270
-800
| -5% | -$26.9K | 0.01% | 520 |
|
|
2021
Q2 | $601K | Sell |
15,070
-395
| -3% | -$15.8K | 0.01% | 437 |
|
|
2021
Q1 | $695K | Sell |
15,465
-1,640
| -10% | -$73.7K | 0.02% | 379 |
|
|
2020
Q4 | $967K | Hold |
17,105
| – | – | 0.03% | 288 |
|
|
2020
Q3 | $812K | Sell |
17,105
-212
| -1% | -$10.1K | 0.02% | 293 |
|
|
2020
Q2 | $1.02M | Sell |
17,317
-255
| -1% | -$15K | 0.03% | 243 |
|
|
2020
Q1 | $831K | Sell |
17,572
-902
| -5% | -$42.7K | 0.03% | 241 |
|
|
2019
Q4 | $1.12M | Buy |
18,474
+500
| +3% | +$30.2K | 0.04% | 241 |
|
|
2019
Q3 | $1.08M | Buy |
17,974
+543
| +3% | +$32.5K | 0.04% | 215 |
|
|
2019
Q2 | $1.12M | Sell |
17,431
-1,787
| -9% | -$115K | 0.04% | 191 |
|
|
2019
Q1 | $1.56M | Buy |
19,218
+2,137
| +13% | +$173K | 0.06% | 141 |
|
|
2018
Q4 | $923K | Sell |
17,081
-2,060
| -11% | -$111K | 0.04% | 191 |
|
|
2018
Q3 | $987K | Buy |
19,141
+2,959
| +18% | +$153K | 0.03% | 179 |
|
|
2018
Q2 | $674K | Buy |
16,182
+3,610
| +29% | +$150K | 0.02% | 220 |
|
|
2018
Q1 | $554K | Sell |
12,572
-12,642
| -50% | -$557K | 0.02% | 253 |
|
|
2017
Q4 | $1.27M | Buy |
25,214
+20,162
| +399% | +$1.01M | 0.04% | 206 |
|
|
2017
Q3 | $256K | Buy |
+5,052
| New | +$256K | 0.01% | 345 |
|